GENTAUR Contact Gentaur

GENTAUR Survey

GENTAUR EUROPE

+32 1658 9045
+32 1650 9045

BELGIUM1

tel +32 2 732 5688
fax +32 2 732 4414
info@gentaur.com
Av. de l' Armée 68
B-1040 Brussels

France

tel 01 43 25 01 50
fax 01 43 25 01 60
9, rue Lagrange
75005 Paris

Italy

tel 02 36 00 65 93
fax 02 36 00 65 94
20135 Milano

Germany

tel +32 16 58 90 45
fax +32 16 50 90 45
Forckenbeckstraße 6
D-52074 Aachen

Japan

tel +81 78 386 0860
fax +81 78 306 0296
Minaatojimaminami-manchi
Chuo-ku, Kobe
065-0047


  • LND1 human melanoma cell line

(Reference #amp-112)

Price: 500 Euro

  • HBL human melanoma cell line

(Reference #amp-111)

Price: 500 euro

RNA Extract:

333.5 Euro / 50 ug

 

HBL & LND1 MELANOMA CELLS references

1:  Zhu N, Lalla R, Eves P, Brown TL, King A, Kemp EH, Haycock JW, MacNeil S.
 Melanoma cell migration is upregulated by tumour necrosis factor-alpha and
suppressed by alpha-melanocyte-stimulating hormone.
Br J Cancer. 2004 Apr 5;90(7):1457-63.

2:  Eves P, Katerinaki E, Simpson C, Layton C, Dawson R, Evans G, Mac Neil S.
Melanoma invasion in reconstructed human skin is influenced by skin
cells--investigation of the role of proteolytic enzymes.
Clin Exp Metastasis. 2003;20(8):685-700.

3:  Eves P, Haycock J, Layton C, Wagner M, Kemp H, Szabo M, Morandini R, Ghanem G, Garcia-Borron JC, Jimenez-Cervantes C, Mac Neil S.
 Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells.
Br J Cancer. 2003 Nov 17;89(10):2004-15.

4:  Katerinaki E, Zhu N, Lalla R, Eves P, Haycock J, Evans G, Ghanem G, Lorigan P, Brown T, MacNeil S.
 PP-16 Does a wound healing environment and the inflammation associated with it promote melanoma invasion?
Pigment Cell Res. 2003 Oct;16(5):598.

5:  Eves P, Kemp EH, Morandini R, Ghanem G, Garcia-Barron JC, Jimenez-Cervantes C, Haycock JW, Mac Neil S.
Alpha-melanocyte stimulating hormone (alpha-MSH) and melanoma invasion: introduction of melanocortin wild-type receptor (MC-1R) into previously alpha-MSH unresponsive cells leads to alpha-MSH inhibition of invasion in transfected cells.
Pigment Cell Res. 2003 Oct;16(5):597-8.

6:  Sanchez J, Jimenez-Cervantes C, Hahmann C, Gerritsen I, Garcia-Borron JC.
 PP-03 Role of G protein coupled receptor kinases in the homologous
desensitization of the human and mouse melanocortin 1 receptors.
Pigment Cell Res. 2003 Oct;16(5):593-4.

7:  Zhu N, Eves PC, Katerinaki E, Szabo M, Morandini R, Ghanem G, Lorigan P,
MacNeil S, Haycock JW.
 Melanoma cell attachment, invasion, and integrin expression is upregulated by tumor necrosis factor alpha and suppressed by alpha melanocyte stimulating hormone.
J Invest Dermatol. 2002 Nov;119(5):1165-71.

8:  Morandini R, Boeynaems JM, Werenne J, Ghanem G.
 Tips and step-by-step protocol for the optimization of important factors
affecting cellular enzyme-linked immunosorbent assay (CELISA).
J Immunoassay Immunochem. 2001;22(4):299-321.

9:  Neil SM, Eves P, Richardson B, Molife R, Lorigan P, Wagner M, Layton C,
Morandini R, Ghanem G.
 Oestrogenic steroids and melanoma cell interaction with adjacent skin cells influence invasion of melanoma cells in vitro.
Pigment Cell Res. 2000;13 Suppl 8:68-72.

10:  Hedley SJ, Murray A, Sisley K, Ghanem G, Morandini R, Gawkrodger DJ, Mac Neil S.
Alpha-melanocyte stimulating hormone can reduce T-cell interaction with
melanoma cells in vitro.
Melanoma Res. 2000 Aug;10(4):323-30.

11:  Haycock JW, Rowe SJ, Cartledge S, Wyatt A, Ghanem G, Morandini R, Rennie IG, MacNeil S.
 Alpha-melanocyte-stimulating hormone reduces impact of proinflammatory cytokine
and peroxide-generated oxidative stress on keratinocyte and melanoma cell lines.
J Biol Chem. 2000 May 26;275(21):15629-36.

12:  Eves P, Layton C, Hedley S, Dawson RA, Wagner M, Morandini R, Ghanem G, Mac Neil S.
 Characterization of an in vitro model of human melanoma invasion based on
reconstructed human skin.
Br J Dermatol. 2000 Feb;142(2):210-22.

13:  Donois E, del Marmol V, Ghanem G, Surleve-Bazeille JE.
 Comparison of HPLC and stereologic image analysis for the quantitation of eu- and pheomelanins in nevus cells and stimulated melanoma cells.
J Invest Dermatol. 1998 Sep;111(3):422-8.

14:  Nguyen H, Ghanem G, Morandini R, Verbist A, Larsimont D, Fallais C,
Fruhling J, Van Houtte P.
 Tumor type and vascularity: important variables in infusional brachytherapy with colloidal 32P.
Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):481-7.

15:  Martinez-Esparza M, Jimenez-Cervantes C, Garcia-Borron JC, Lozano JA, del Marmol V, Ghanem G, Solano F.
 Comparison of TRPs from murine and human malignant melanocytes.
Pigment Cell Res. 1997 Aug;10(4):229-35.

16:  Loir B, Bouchard B, Morandini R, Del Marmol V, Deraemaecker R,
Garcia-Borron JC, Ghanem G.
 Immunoreactive alpha-melanotropin as an autocrine effector in human melanoma cells.
Eur J Biochem. 1997 Mar 15;244(3):923-30.

17:  Pansky A, Peng F, Eberhard M, Baselgia L, Siegrist W, Baumann JB, Eberle
AN, Beglinger C, Hildebrand P.
 Identification of functional GRP-preferring bombesin receptors on human
melanoma cells.
Eur J Clin Invest. 1997 Jan;27(1):69-76.

18:  Bagutti C, Oestreicher M, Siegrist W, Oberholzer M, Eberle AN.
 alpha-MSH receptor autoradiography on mouse and human melanoma tissue sections and biopsies.
J Recept Signal Transduct Res. 1995 Jan-Mar;15(1-4):427-42.

19:  Siegrist W, Sauter P, Eberle AN.
 A selective protein kinase C inhibitor (CGP 41251) positively and negatively modulates melanoma cell MSH receptors.
J Recept Signal Transduct Res. 1995 Jan-Mar;15(1-4):283-96.

20:  Tapia JC, Bagutti C, Wikberg JS, Chhajlani V, Eberle AN.
 Stable expression of the human MSH receptor in a mouse melanoma cell line.
J Recept Signal Transduct Res. 1995 Jan-Mar;15(1-4):43-53.

21:  Siegrist W, Stutz S, Eberle AN.
 Homologous and heterologous regulation of alpha-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines.
Cancer Res. 1994 May 15;54(10):2604-10.

22:  del Marmol V, Solano F, Sels A, Huez G, Libert A, Lejeune F, Ghanem G.
 Glutathione depletion increases tyrosinase activity in human melanoma cells.
J Invest Dermatol. 1993 Dec;101(6):871-4.

23:  Siegrist W, Eberle AN.
 Homologous regulation of the MSH receptor in melanoma cells.
J Recept Res. 1993;13(1-4):263-81.

24:  Bagutti C, Eberle AN.
 Synthesis and biological properties of a biotinylated derivative of ACTH1-17 for MSH receptor studies.
J Recept Res. 1993;13(1-4):229-44.

25:  Mascagna D, Ghanem G, Morandini R, d'Ischia M, Misuraca G, Lejeune F, Prota G.
 Synthesis and cytotoxic properties of new N-substituted 4-aminophenol
derivatives with a potential as antimelanoma agents.
Melanoma Res. 1992 May;2(1):25-32.

26:  Atassi G, Berlion M, el Oche Y, Bizzari JP.
 Characterization of the pharmacological antitumor effects of S 12363, a new vinca alkaloid.
Anticancer Res. 1991 Mar-Apr;11(2):975-80.

27:  Giorgi-Renault S, Renault J, Gebel-Servolles P, Baron M, Paoletti C, Cros S, Bissery MC, Lavelle F, Atassi G.
 Heterocyclic quinones. 17. A new in vivo active antineoplastic drug:
6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8-
quinazolinedione.
J Med Chem. 1991 Jan;34(1):38-46.

28:  Deschodt-Lanckman M, Vanneste Y, Loir B, Michel A, Libert A, Ghanem G,
Lejeune F.
 Degradation of alpha-melanocyte stimulating hormone (alpha-MSH) by
CALLA/endopeptidase 24.11 expressed by human melanoma cells in culture.
Int J Cancer. 1990 Dec 15;46(6):1124-30.

29:  Arnould R, Dubois J, Abikhalil F, Libert A, Ghanem G, Atassi G, Hanocq M, Lejeune FJ.
 Compared cytotoxicity effects of five anticancer drugs on human (HBL) and mouse (B16) melanoma cells in vitro.
Anticancer Res. 1990 May-Jun;10(3):789-93.

30:  Kiss R, de Launoit Y, Gras S, Thibaut S, Atassi G.
 A new assay to evaluate cell growth and drug sensitivity in culture using a cell image processor.
Anticancer Res. 1988 Jul-Aug;8(4):765-74.

send mail to webmaster@gentaur.com with questions or comments about this web site.
Copyright © 2008 Gentaur Molecular Products
Site powered by Acid Dragon (AC)
Last modified: 05/19/16